GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vytrus Biotech SA (XMAD:VYT) » Definitions » Ending Cash Position

Vytrus Biotech (XMAD:VYT) Ending Cash Position : €2.22 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Vytrus Biotech Ending Cash Position?

Vytrus Biotech's Ending Cash Position for the quarter that ended in Jun. 2024 was €2.22 Mil.

Vytrus Biotech's quarterly Ending Cash Position declined from Jun. 2023 (€1.12 Mil) to Dec. 2023 (€1.11 Mil) but then increased from Dec. 2023 (€1.11 Mil) to Jun. 2024 (€2.22 Mil).

Vytrus Biotech's annual Ending Cash Position declined from Dec. 2021 (€1.28 Mil) to Dec. 2022 (€0.73 Mil) but then increased from Dec. 2022 (€0.73 Mil) to Dec. 2023 (€1.11 Mil).


Vytrus Biotech Ending Cash Position Historical Data

The historical data trend for Vytrus Biotech's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vytrus Biotech Ending Cash Position Chart

Vytrus Biotech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial - - 1.28 0.73 1.11

Vytrus Biotech Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.07 0.73 1.12 1.11 2.22

Vytrus Biotech Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Vytrus Biotech's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.725+0.38
=1.11

Vytrus Biotech's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=1.105+1.114
=2.22


Vytrus Biotech Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Vytrus Biotech's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Vytrus Biotech Business Description

Traded in Other Exchanges
N/A
Address
Sant Gaieta 121, 2nd, Terrassa, Barcelona, ESP, 08221
Vytrus Biotech SA develops natural active ingredients on an industrial scale. The natural actives offered by the company include Nectaria Lithops, Olea Vitae, Turmeric zen, Capilia Longa, Qura Noni.

Vytrus Biotech Headlines

No Headlines